Trends in heart failure hospitalizations

Current Heart Failure Reports

Volumn 9, Issue 4, 2012, Pages 346-353

  Fida, Nadia ^a   Piña, Ileana L ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Emergency department; European heart failure hospitalizations; Heart failure hospitalizations; Multidisciplinary team care; Patient demographics; Readmissions

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ACUTE CORONARY SYNDROME; AMBULATORY CARE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOGENIC SHOCK; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; COST CONTROL; DEVELOPED COUNTRY; DIABETES MELLITUS; DIAGNOSIS RELATED GROUP; DISEASE REGISTRY; EMERGENCY WARD; EUROPE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MEDICAID; NURSING HOME; PALLIATIVE THERAPY; PATIENT EDUCATION; POPULATION GROWTH; REIMBURSEMENT; REVASCULARIZATION; TOTAL QUALITY MANAGEMENT; UNITED STATES;

EMERGENCY SERVICE, HOSPITAL; HEART FAILURE; HOSPITALIZATION; HUMANS; PATIENT CARE TEAM; PATIENT READMISSION;

EID: 84872203204     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-012-0117-5     Document Type: Article

References (41)

1. O'connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1439-50.
2. Whellan DJ, O'connor CM, Ousdigian KT, Lung TH. Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF). Am Heart J. 2008;156:833-9. 839.
3. Fang J, Mensah GA, Croft JB, Keenan NL. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol. 2008;52:428-34.
4. Adams Jr KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209-16.
5. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, et al. Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. Am Heart J. 2007;154:12-38.
6. Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol. 2007;50:768-77.
7. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27:2725-36.
8. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol. 2006;47:76-84.
9. Rich MW. Heart failure in the 21st century: a cardiogeriatric syndrome. J Gerontol A Biol Sci Med Sci. 2001;56:M88-96.
10. Chen J, Normand SL,Wang Y, KrumholzHM. National and regional trends in heart failure hospitalization and mortality rates forMedicare beneficiaries, 1998-2008. JAMA. 2011;306:1669-78.
11. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993;22:6A-13A. (Pubitemid 23285789)
12. Ross JS, Chen J, Lin Z, Bueno H, Curtis JP, Keenan PS, et al. Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail. 2010;3:97-103.
13. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics -2010 update: a report from the American Heart Association. Circulation. 2010;121:e46-e215.
14. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2007;153:1021-28. (Pubitemid 46809844)
15. Smith NL, Psaty BM, Pitt B, Garg R, Gottdiener JS, Heckbert SR. Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995. Arch Intern Med. 1998;158:1074-80.
16. Karasek J, Widimsky P, Ostadal P, Hrabakova H, Penicka M. Acute heart failure registry from high-volume university hospital ED: comparing European and US data. Am J Emerg Med. 2012;30:695-705.
17. Konstam MA, Gheorghiade M, Burnett Jr JC, Grinfeld L, Maggioni AP, Swedberg K, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007;297:1319-31.
18. Blair JE, Zannad F, Konstam MA, Cook T, Traver B, Burnett Jr JC, et al. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. J Am Coll Cardiol. 2008;52:1640-8.
19. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418-28. A thoughtful look from the CDC at the issue of readmissions for patients who have been hospitalized with HF. In addition, the now quoted number of 52% of patients never seen within the first 30 days post discharge.
20. Peacock WF, Emerman CL. Emergency department management of patients with acute decompensated heart failure. Heart Fail Rev. 2004;9:187-93.
21. Luchner A, Mockel M, Spanuth E, Mocks J, Peetz D, Baum H, et al. N-Terminal pro brain natriuretic peptide in the management of patients in the medical emergency department (PROMPT): correlation with disease severity, utilization of hospital resources, and prognosis in a large, prospective, randomized multicentre trial. Eur J Heart Fail. 2012;14:259-67.
22. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-Type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-67. (Pubitemid 34764819)
23. Peacock WF, Fonarow GC, Ander DS, Collins SP, Gheorghiade M, Kirk JD, et al. Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient-parts 1-6. Acute Card Care. 2009;11:3-42.
24. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'connor CM, She L, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296:2217-26.
25. Hasselblad V, Gattis SW, Shah MR, Lokhnygina Y, O'connor CM, Califf RM, et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail. 2007;9:1064-69. (Pubitemid 47451811)
26. Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail. 2002;8:136-41.
27. Peacock WF, Costanzo MR, De Marco T, Lopatin M, Wynne J, Mills RM, et al. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology. 2009;113:12-9.
28. Weintraub NL, Collins SP, Pang PS, Levy PD, Anderson AS, Arslanian-Engoren C, et al. Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. Circulation. 2010;122:1975-96.
29. Stewart S, McAlister FA, McMurray JJ. Heart failure management programs reduce readmissions and prolong survival. Arch Intern Med. 2005;165:1311-12. (Pubitemid 40989599)
30. Institute of Medicine. Crossing the Quality Chasm:A new health system for the 21st century. Washington: National Academy Press; 2001.
31. Bonow RO, Bennett S, Casey Jr DE, Ganiats TG, Hlatky MA, Konstam MA, et al. ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society of America. Circulation. 2005;112:1853-87.
32. Fonarow GC, Albert NM, Curtis AB, Gheorghiade M, Liu Y, Mehra M, et al. Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HF. J Am HeartAssoc. 2012;1:16-26. A contemporary look at an HF registry once again showing that if evidence-based care is consistently applied in patients with HF, they ultimately have better outcomes. Over 15,000 patients included.
33. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. The Fourth INTERMACS Annual Report: 4,000 implants and counting. J Heart Lung Transplant. 2012;31:117-26.
34. Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates -2006. J Heart Lung Transplant. 2006;25:1024-42.
35. Sandner SE, Zimpfer D, Zrunek P, Rajek A, Schima H, Dunkler D, et al. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation. J Heart Lung Transplant. 2009;28:367-72.
36. Stepanenko A, Potapov EV, Jurmann B, Lehmkuhl HB, Dandel M, Siniawski H, et al. Outcomes of elective versus emergent permanent mechanical circulatory support in the elderly: a single-center experience. J Heart Lung Transplant. 2010;29:61-5.
37. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009
38. West R, Liang L, Fonarow GC, Kociol R, Mills RM, O'connor CM, et al. Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHEREUS registry and ADHERE-International registry. Eur J Heart Fail. 2011;13:945-52.
39. Atherton JJ, Hayward CS, Wan Ahmad WA, Kwok B, Jorge J, Hernandez AF, et al. Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific). J Card Fail. 2012;18:82-8.
40. Krantz MJ, Ambardekar AV, Kaltenbach L, Hernandez AF, Heidenreich PA, Fonarow GC. Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure). Am J Cardiol. 2011;107:1818-23.
41. Fonarow GC, Abraham WT, Albert NM, Gattis SW, Gheorghiade M, Greenberg BH, et al. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Arch Intern Med. 2007;167:1493-502.